We identified significantly enhanced tumor-associated neovascular PSMA expression in primary cholangiocarcinoma and not identified in metastatic pancreatic ductal adenocarcinoma. This evidence concerns the gene FOLH1 and pancreatic ductal adenocarcinoma.